论文部分内容阅读
目的观察海捷亚与拜新同联合应用治疗原发性高血压的效果。方法将72例原发性高血压患者随机分成两组,治疗组联合应用海捷亚与拜新同治疗,对照组单纯使用拜新同治疗。结果治疗结束后,对照组36例中,总有效率63.9%;治疗组36例中,总有效率91.7%。与对照组相比,治疗组控制高血压的疗效具有明显优势(P<0.05)。两组都无明显不良反应。结论海捷亚与拜新同联合应用对原发性高血压具有良好的降压效果,值得临床推广。
Objective To observe the effect of Haijie Ya and Baixin on the treatment of essential hypertension. Methods Seventy-two patients with essential hypertension were randomly divided into two groups. The treatment group was treated with Hae-jia and Baixin, while the control group was treated with Baixin alone. Results After treatment, the control group 36 cases, the total effective rate 63.9%; treatment group 36 cases, the total effective rate 91.7%. Compared with the control group, the treatment group has obvious advantages in the control of hypertension (P <0.05). No significant adverse reactions in both groups. Conclusions Haijie Ya and Baixin with the joint use of good antihypertensive effect of essential hypertension, worthy of clinical promotion.